A detailed history of United Capital Financial Advisers, LLC transactions in Illumina, Inc. stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 5,816 shares of ILMN stock, worth $761,488. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,816
Previous 5,311 9.51%
Holding current value
$761,488
Previous $554,000 36.82%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$105.28 - $135.9 $53,166 - $68,629
505 Added 9.51%
5,816 $758,000
Q2 2024

Aug 14, 2024

SELL
$101.05 - $133.57 $216,247 - $285,839
-2,140 Reduced 28.72%
5,311 $554,000
Q1 2024

May 15, 2024

BUY
$127.73 - $147.2 $60,544 - $69,772
474 Added 6.79%
7,451 $1.02 Million
Q4 2023

Feb 14, 2024

BUY
$92.79 - $142.53 $281,153 - $431,865
3,030 Added 76.77%
6,977 $971,000
Q3 2023

Nov 14, 2023

SELL
$128.91 - $192.44 $85,080 - $127,010
-660 Reduced 14.33%
3,947 $541,000
Q2 2023

Aug 14, 2023

SELL
$183.43 - $232.67 $285,050 - $361,569
-1,554 Reduced 25.22%
4,607 $863,000
Q1 2023

Aug 14, 2023

BUY
$193.75 - $232.55 $301,087 - $361,382
1,554 Added 33.73%
6,161 $1.43 Million
Q1 2023

May 15, 2023

SELL
$193.75 - $232.55 $1.48 Million - $1.77 Million
-7,616 Reduced 55.28%
6,161 $1.43 Million
Q4 2022

Feb 14, 2023

SELL
$187.24 - $242.74 $122,642 - $158,994
-655 Reduced 4.54%
13,777 $2.79 Million
Q3 2022

Nov 14, 2022

SELL
$177.23 - $227.44 $195,661 - $251,093
-1,104 Reduced 7.11%
14,432 $2.75 Million
Q2 2022

Aug 11, 2022

SELL
$181.58 - $368.0 $150,711 - $305,440
-830 Reduced 5.07%
15,536 $2.86 Million
Q1 2022

May 16, 2022

SELL
$303.87 - $423.8 $194,172 - $270,808
-639 Reduced 3.76%
16,366 $5.72 Million
Q4 2021

Feb 14, 2022

BUY
$347.28 - $421.83 $580,999 - $705,721
1,673 Added 10.91%
17,005 $6.47 Million
Q3 2021

Nov 15, 2021

SELL
$405.61 - $524.84 $488,354 - $631,907
-1,204 Reduced 7.28%
15,332 $6.22 Million
Q2 2021

Aug 13, 2021

SELL
$372.84 - $481.5 $190,148 - $245,565
-510 Reduced 2.99%
16,536 $7.83 Million
Q1 2021

May 14, 2021

SELL
$361.28 - $504.76 $1.32 Million - $1.84 Million
-3,645 Reduced 17.62%
17,046 $6.55 Million
Q4 2020

Feb 17, 2021

SELL
$292.7 - $370.96 $334,263 - $423,636
-1,142 Reduced 5.23%
20,691 $7.66 Million
Q3 2020

Nov 13, 2020

SELL
$268.51 - $400.74 $3.31 Million - $4.94 Million
-12,333 Reduced 36.1%
21,833 $6.75 Million
Q2 2020

Aug 13, 2020

BUY
$256.46 - $373.01 $3.44 Million - $5 Million
13,400 Added 64.53%
34,166 $12.7 Million
Q1 2020

May 15, 2020

SELL
$209.2 - $335.53 $821,946 - $1.32 Million
-3,929 Reduced 15.91%
20,766 $5.67 Million
Q4 2019

Feb 14, 2020

BUY
$288.29 - $335.49 $159,712 - $185,861
554 Added 2.29%
24,695 $8.19 Million
Q3 2019

Nov 14, 2019

SELL
$266.84 - $378.23 $644,952 - $914,181
-2,417 Reduced 9.1%
24,141 $7.34 Million
Q2 2019

Aug 13, 2019

SELL
$300.59 - $368.15 $3.5 Million - $4.29 Million
-11,643 Reduced 30.48%
26,558 $9.78 Million
Q1 2019

May 14, 2019

BUY
$272.57 - $321.18 $79,317 - $93,463
291 Added 0.77%
38,201 $11.9 Million
Q4 2018

Feb 14, 2019

BUY
$272.46 - $366.54 $312,784 - $420,787
1,148 Added 3.12%
37,910 $11.4 Million
Q3 2018

Nov 14, 2018

SELL
$279.04 - $367.06 $451,486 - $593,903
-1,618 Reduced 4.22%
36,762 $13.5 Million
Q2 2018

Aug 14, 2018

BUY
$228.17 - $292.07 $67,994 - $87,036
298 Added 0.78%
38,380 $10.7 Million
Q1 2018

May 15, 2018

BUY
$209.54 - $253.91 $482,780 - $585,008
2,304 Added 6.44%
38,082 $9 Million
Q4 2017

Feb 13, 2018

BUY
$202.23 - $230.03 $924,393 - $1.05 Million
4,571 Added 14.65%
35,778 $7.78 Million
Q3 2017

Nov 14, 2017

SELL
$172.3 - $213.93 $62,889 - $78,084
-365 Reduced 1.16%
31,207 $6.22 Million
Q2 2017

Aug 14, 2017

BUY
N/A
31,572
31,572 $5.48 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $20.6B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.